Sanofi S.A. Pfizer Inc. AstraZeneca Plc
GlaxoSmithKline Plc
F. Hoffmann-La Roche AG (Roche AG)
Eli Lilly and Company
Johnson & Johnson
Abbott Laboratories
Novartis AG and Teva Pharmaceutical Limited
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 149 | iMarc Group | ASDR-639939 |
Sanofi S.A. Pfizer Inc. AstraZeneca Plc
GlaxoSmithKline Plc
F. Hoffmann-La Roche AG (Roche AG)
Eli Lilly and Company
Johnson & Johnson
Abbott Laboratories
Novartis AG and Teva Pharmaceutical Limited